Terns Pharmaceuticals Long Term Debt

Terns Pharmaceuticals (TERN) currently reports a long-term debt of $450K as of December 2025. That compares with $920K in the prior-year period — down 51.6% year over year. Use the charts on this page to explore Terns Pharmaceuticals's long-term debt history and peer comparisons.

Terns Pharmaceuticals's long-term debt decreased from $920K to $450K — a 51.6% year-over-year decrease (period ending December 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Terns Pharmaceuticals reported $450K in long-term debt as of December 2025. That compares with $920K in the prior-year period — down 51.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $450K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Terns Pharmaceuticals, and consider following TERN for alerts when major investors trade the stock.

Terns Pharmaceuticals is classified in the Healthcare sector. On long-term debt, it currently shows $450K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing TERN with unrelated industries.